Suppr超能文献

低剂量奥氮平治疗中枢性眩晕:2例报告

Treatment of Central Vertigo With Low Dose Olanzapine: Report of Two Cases.

作者信息

Jiang Connie, Lekshminarayanan Anusha, Balkaya Ihsan, Uddin Alal, Bavishi Sheital, Altschuler Eric

机构信息

Physical Medicine and Rehabilitation, Private Practice, Fairfax, USA.

Physical Medicine and Rehabilitation, Metropolitan Hospital Center, New York, USA.

出版信息

Cureus. 2022 Feb 27;14(2):e22647. doi: 10.7759/cureus.22647. eCollection 2022 Feb.

Abstract

Good treatments are available for many cases of vertigo due to a peripheral cause such as benign paroxysmal positional vertigo. Conversely, vertigo secondary to a central lesion remains a treatment challenge typically without good pharmacologic or other treatments. We have successfully treated two patients, the first to our knowledge, with central vertigo, one from brain injury, one after stroke, with low dose olanzapine which we found to quickly and dramatically resolve vertigo and permit functional normalization. In our two cases, we found that a low dose of olanzapine 2.5mg daily (typical dosing of olanzapine for the psychiatric disease is 5-20mg daily) caused vertigo to rapidly and dramatically remit. Interestingly, our two cases had different causes and possibly lesion locations.

摘要

对于许多由外周原因引起的眩晕病例,如良性阵发性位置性眩晕,有有效的治疗方法。相反,继发于中枢病变的眩晕仍然是一个治疗挑战,通常没有良好的药物或其他治疗方法。据我们所知,我们已成功治疗了两名患有中枢性眩晕的患者,一名因脑损伤,一名中风后,使用低剂量奥氮平,我们发现其能迅速且显著地缓解眩晕并使功能恢复正常。在我们的两个病例中,我们发现每日低剂量奥氮平2.5毫克(奥氮平用于精神疾病的典型剂量为每日5 - 20毫克)可使眩晕迅速且显著缓解。有趣的是,我们的两个病例病因不同,病变位置可能也不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facd/8882308/28b20ab23ea5/cureus-0014-00000022647-i01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验